Mark Bolstridge
Impact in
- Clinical Psychology top 0.2%
- Psychedelics and Drug Studies
- Cognitive Neuroscience top 5%
- Functional Brain Connectivity Studies
- Neural dynamics and brain function
Papers in
-
- Psychedelics and Drug Studies 16
-
- Schizophrenia research and treatment 2
- Co-authors
- David Nutt (14 shared papers)Robin Lester Carhart-Harris (13 shared papers)Mendel Kaelen (11 shared papers)Amanda Feilding (11 shared papers)David Erritzøe (4 shared papers)Michael Bloomfield (4 shared papers)Camilla Day (2 shared papers)David M. Taylor (2 shared papers)
- Journals
- Psychopharmacology (3 papers)Biological Psychiatry (2 papers)European Neuropsychopharmacology (1 paper)Current Biology (1 paper)BJPsych Open (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mark Bolstridge
19 papers receiving 4.5k citations
Mark Bolstridge's Hit Papers
Peers
Comparison fields: 5 of 97
- Clinical Psychology 3.9k
- Cognitive Neuroscience 347
- Pharmacology 245
- Experimental and Cognitive Psychology 135
- Biological Psychiatry 10
Countries citing papers authored by Mark Bolstridge
This map shows the geographic impact of Mark Bolstridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bolstridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bolstridge more than expected).
Fields of papers citing papers by Mark Bolstridge
This network shows the impact of papers produced by Mark Bolstridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bolstridge. The network helps show where Mark Bolstridge may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Bolstridge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study Hit paper breakdown → | 2016 | 1164 |
| 2 | Psilocybin with psychological support for treatment-resistant depression: six-month follow-up Hit paper breakdown → | 2017 | 729 |
| 3 | Neural correlates of the LSD experience revealed by multimodal neuroimaging Hit paper breakdown → | 2016 | 623 |
| 4 | Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms Hit paper breakdown → | 2017 | 436 |
| 5 | Broadband Cortical Desynchronization Underlies the Human Psychedelic State Hit paper breakdown → | 2013 | 367 |
| 6 | Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution Hit paper breakdown → | 2016 | 358 |
| 7 | 2016 | 247 | |
| 8 | 2014 | 245 | |
| 9 | 2014 | 121 | |
| 10 | 2015 | 115 | |
| 11 | 2016 | 97 | |
| 12 | 2013 | 86 | |
| 13 | 2016 | 37 | |
| 14 | 2016 | 36 | |
| 15 | 2017 | 30 | |
| 16 | 2020 | 28 | |
| 17 | 2017 | 11 | |
| 18 | 2017 | 6 | |
| 19 | 2020 | 1 |
About Mark Bolstridge
Mark Bolstridge is a scholar working on Clinical Psychology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Experimental and Cognitive Psychology and Epidemiology, having authored 19 papers that have together received 4.7k indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (16 papers), Schizophrenia research and treatment (2 papers), Neurotransmitter Receptor Influence on Behavior (1 paper), Substance Abuse Treatment and Outcomes (1 paper) and Multisensory perception and integration (1 paper). The work is most often cited by research in Clinical Psychology (3.9k citations), Cognitive Neuroscience (347 citations), Pharmacology (245 citations), Experimental and Cognitive Psychology (135 citations) and Biological Psychiatry (10 citations). Mark Bolstridge has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include David Nutt, Robin Lester Carhart-Harris, Mendel Kaelen, Amanda Feilding, David Erritzøe, Michael Bloomfield, Camilla Day, David M. Taylor, James Rucker and Helen Valerie Curran. Their work appears in journals such as Psychopharmacology, Biological Psychiatry, European Neuropsychopharmacology, Current Biology and BJPsych Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.